Literature DB >> 24613538

Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome.

Jin Ju Kim1, Kyu Ri Hwang2, Young Min Choi3, Shin Yong Moon4, Soo Jin Chae5, Chan Woo Park6, Hye Ok Kim6, Doo Seok Choi7, Hyuck Chan Kwon8, Byung Moon Kang9, Byung Seok Lee10, Si Hyun Cho10, Tai June Kim11, Tak Kim12, Min Ju Kim13, Hyun Young Park13.   

Abstract

OBJECTIVE: To investigate the complete metabolic and phenotypic profiles of a large cohort of untreated, consecutively recruited Korean women with polycystic ovary syndrome (PCOS), for whom a registry for Korean women with PCOS was constructed.
DESIGN: Observational study.
SETTING: Three infertility clinics and 10 university hospitals. PATIENT(S): Eight hundred sixty-five women with PCOS were recruited using the Rotterdam criteria. INTERVENTION(S): Standardized evaluation protocol and web-based case report form. MAIN OUTCOME MEASURE(S): Metabolic and phenotypic profiles. RESULT(S): The subjects with PCOS mainly consisted of young and nonobese women. The most problematic subjective symptom was menstrual disturbance or infertility, and, on average, the patients seemed to menstruate every 2 months. PCO morphology was observed in 96.5% of the patients. Although few women visited hospitals owing to HA symptoms alone, hirsutism was observed in one-third of the patients (33.9%) and half (47.4%) of the patients had biochemical HA. About one-fifth (20.1%) of the patients had generalized obesity, and one-third (33.2%) had central obesity. Prevalence of dyslipidemia, diabetes, hypertension, and metabolic syndrome were 35.7%, 3.5%, 4.0%, and 13.7%, respectively. Prevalence of prediabetes was 20.8%, and a substantial proportion of additional subjects with normal fasting plasma glucose or oral glucose tolerance tests were identified as having prediabetes by hemoglobin A1C testing. CONCLUSION(S): Our well-defined cohort provided comprehensive estimates of the features of metabolic and phenotypic profiles related to PCOS in Korean women. Further longitudinal follow-up studies are needed to investigate the changes in phenotypic and metabolic markers in this PCOS cohort.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metabolic syndrome; Rotterdam criteria; phenotype; polycystic ovary syndrome; type 2 diabetes

Mesh:

Year:  2014        PMID: 24613538     DOI: 10.1016/j.fertnstert.2014.01.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.

Authors:  Patricia A Hunt; Sheela Sathyanarayana; Paul A Fowler; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2016-03-22       Impact factor: 5.958

2.  Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome.

Authors:  Tao Du; Yu Duan; Kaiwen Li; Xiaomiao Zhao; Renmin Ni; Yu Li; Dongzi Yang
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

3.  Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study.

Authors:  Hui Li; Lin Li; Jian Gu; Yu Li; Xiaoli Chen; Dongzi Yang
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

4.  Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome.

Authors:  L Afifi; L Saeed; L A Pasch; H G Huddleston; M I Cedars; L T Zane; K Shinkai
Journal:  Int J Womens Dermatol       Date:  2017-03-13

5.  Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome.

Authors:  Havagiray R Chitme; Eman A K Al Azawi; Anfal M Al Abri; Buthina M Al Busaidi; Zamzam K A Salam; Maisa M Al Taie; Saja K Al Harbo
Journal:  J Taibah Univ Med Sci       Date:  2017-01-13

6.  Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women.

Authors:  Roshan Dadachanji; Anushree Patil; Beena Joshi; Srabani Mukherjee
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

Review 7.  Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.

Authors:  Antonio Mancini; Carmine Bruno; Edoardo Vergani; Claudia d'Abate; Elena Giacchi; Andrea Silvestrini
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

8.  Circulating levels of Meteorin-like protein in polycystic ovary syndrome: A case-control study.

Authors:  Fatima Zahraa Fouani; Reza Fadaei; Nariman Moradi; Zahra Zandieh; Soheila Ansaripour; Mir Saeed Yekaninejad; Akram Vatannejad; Maryam Mahmoudi
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

9.  Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles.

Authors:  Rhea Jabbour; Johannes Ott; Wolfgang Eppel; Peter Frigo
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.